BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 27-12-2024
Asset Class:
Benchmark: BSE Healthcare TRI
Expense Ratio: 2.37% As on (28-11-2025)
Status: Open Ended Schemes
Minimum Investment: 500.0
Minimum Topup: 100.0
Total Assets: 338.78 Cr As on (28-11-2025)
Turn over: -
NAV as on 08-01-2026

9.711

-0.14 (-1.4623%)

CAGR Since Inception

-3.56%

BSE Healthcare TRI 14.79%

PERFORMANCE of BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Scheme Performance (%)

Data as on - 08-01-2026

Yearly Performance (%)

Fund Managers

FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)

Investment Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.

NAV & Lumpsum details( Invested amount 1,00,000)

Show All Monthly Lumpsum Returns
NAV Date NAV Units Market
Value
Returns
(%)
30-12-2024 10.079 9921.6192 100000 0.0 %
30-01-2025 9.363 - 92896 -7.1 %
28-02-2025 8.519 - 84522 -15.48 %
28-03-2025 9.08 - 90088 -9.91 %
28-04-2025 9.27 - 91973 -8.03 %
28-05-2025 9.385 - 93114 -6.89 %
30-06-2025 9.693 - 96170 -3.83 %
28-07-2025 9.9 - 98224 -1.78 %
28-08-2025 9.647 - 95714 -4.29 %
29-09-2025 9.472 - 93978 -6.02 %
28-10-2025 9.833 - 97559 -2.44 %
28-11-2025 9.919 - 98413 -1.59 %
29-12-2025 9.612 - 95367 -4.63 %
08-01-2026 9.711 - 96349 -3.65 %

RETURNS CALCULATOR for BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

riskometer

Key Performance and Risk Statistics of BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Amount :
Start :
End :
Period
Data as on - 08-01-2026
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH 27-12-2024 -3.05 0.0 0.0 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 3.0 23.23 0.0 0.0 0.0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 06-02-2024 0.92 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 0.03 19.67 27.44 16.94 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -1.01 15.9 22.33 14.84 0.0
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -1.85 13.7 22.15 12.97 0.0
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -2.01 13.03 22.15 14.43 13.55
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -2.75 16.74 24.3 14.33 11.96
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 -3.19 16.31 20.37 11.43 0.0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -3.21 14.8 22.35 14.52 11.86

PORTFOLIO ANALYSIS of BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Asset Allocation (%)

Allocation Percentage (%)

Market Cap Distribution

Small Cap

34.47%

Others

6.89%

Large Cap

37.82%

Mid Cap

20.82%

Total

100%